Keudell/Morrison Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Sell |
646
-307
| -32% | -$124K | 0.06% | 184 |
|
|
2025
Q1 | $474K | Sell |
953
-1
| -0.1% | -$498 | 0.11% | 115 |
|
|
2024
Q4 | $496K | Sell |
954
-173
| -15% | -$90K | 0.13% | 106 |
|
|
2024
Q3 | $697K | Buy |
1,127
+1
| +0.1% | +$619 | 0.19% | 90 |
|
|
2024
Q2 | $623K | Buy |
1,126
+120
| +12% | +$66.4K | 0.18% | 96 |
|
|
2024
Q1 | $585K | Buy |
1,006
+366
| +57% | +$213K | 0.18% | 99 |
|
|
2023
Q4 | $340K | Sell |
640
-87
| -12% | -$46.2K | 0.11% | 141 |
|
|
2023
Q3 | $368K | Buy |
727
+24
| +3% | +$12.1K | 0.11% | 121 |
|
|
2023
Q2 | $367K | Sell |
703
-59
| -8% | -$30.8K | 0.11% | 124 |
|
|
2023
Q1 | $439K | Sell |
762
-5
| -0.7% | -$2.88K | 0.13% | 103 |
|
|
2022
Q4 | $422K | Buy |
767
+143
| +23% | +$78.7K | 0.14% | 100 |
|
|
2022
Q3 | $316K | Buy |
624
+6
| +1% | +$3.04K | 0.12% | 127 |
|
|
2022
Q2 | $336K | Sell |
618
-63
| -9% | -$34.3K | 0.12% | 125 |
|
|
2022
Q1 | $402K | Buy |
681
+5
| +0.7% | +$2.95K | 0.17% | 118 |
|
|
2021
Q4 | $451K | Sell |
676
-138
| -17% | -$92.1K | 0.18% | 105 |
|
|
2021
Q3 | $465K | Sell |
814
-1
| -0.1% | -$571 | 0.2% | 106 |
|
|
2021
Q2 | $411K | Sell |
815
-12
| -1% | -$6.05K | 0.23% | 110 |
|
|
2021
Q1 | $377K | Sell |
827
-141
| -15% | -$64.3K | 0.22% | 111 |
|
|
2020
Q4 | $451K | Hold |
968
| – | – | 0.29% | 96 |
|
|
2020
Q3 | $427K | Sell |
968
-22
| -2% | -$9.71K | 0.27% | 89 |
|
|
2020
Q2 | $359K | Sell |
990
-16
| -2% | -$5.8K | 0.3% | 96 |
|
|
2020
Q1 | $285K | Sell |
1,006
-30
| -3% | -$8.5K | 0.28% | 105 |
|
|
2019
Q4 | $337K | Buy |
1,036
+23
| +2% | +$7.48K | 0.23% | 107 |
|
|
2019
Q3 | $295K | Hold |
1,013
| – | – | 0.24% | 112 |
|
|
2019
Q2 | $278K | Sell |
1,013
-11
| -1% | -$3.02K | 0.24% | 113 |
|
|
2019
Q1 | $280K | Buy |
+1,024
| New | +$280K | 0.25% | 105 |
|